This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.
Company Profile:
Mirum Pharmaceuticals, Inc.
Market Cap (USD):
$1.62 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Morphic Holding, Inc.
Market Cap (USD):
$1.59 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Kura Oncology, Inc.
Market Cap (USD):
$1.52 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Keros Therapeutics, Inc.
Market Cap (USD):
$1.52 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Ligand Pharmaceuticals Incorporated
Market Cap (USD):
$1.52 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Zogenix, Inc.
Market Cap (USD):
$1.49 B
(March 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Akero Therapeutics, Inc.
Market Cap (USD):
$1.48 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Dynavax Technologies Corporation
Market Cap (USD):
$1.47 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
MannKind Corporation
Market Cap (USD):
$1.40 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Longboard Pharmaceuticals, Inc.
Market Cap (USD):
$1.36 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
BioCryst Pharmaceuticals, Inc.
Market Cap (USD):
$1.35 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Arcus Biosciences, Inc.
Market Cap (USD):
$1.28 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Ardelyx, Inc.
Market Cap (USD):
$1.24 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Arcutis Biotherapeutics, Inc.
Market Cap (USD):
$1.21 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Day One Biopharmaceuticals, Inc.
Market Cap (USD):
$1.20 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Nurix Therapeutics, Inc.
Market Cap (USD):
$1.19 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Vir Biotechnology, Inc.
Market Cap (USD):
$1.16 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Sana Biotechnology, Inc.
Market Cap (USD):
$1.13 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Xencor, Inc.
Market Cap (USD):
$1.12 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
4D Molecular Therapeutics, Inc.
Market Cap (USD):
$1.09 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Tarsus Pharmaceuticals, Inc.
Market Cap (USD):
$1.05 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Ocular Therapeutix, Inc.
Market Cap (USD):
$1.03 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Alpine Immune Sciences, Inc.
Market Cap (USD):
$1.03 B
(Jan. 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Innoviva, Inc.
Market Cap (USD):
$1.02 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Forma Therapeutics Holdings, Inc.
Market Cap (USD):
$1.01 B
(Oct. 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Liquidia Corporation
Market Cap (USD):
$934.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Cullinan Management, Inc.
Market Cap (USD):
$932.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Liquidia Corp
Market Cap (USD):
$928.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Cogent Biosciences, Inc.
Market Cap (USD):
$922.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Provention Bio, Inc.
Market Cap (USD):
$912.0 M
(Jan. 1, 2023)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology